In the Journals

Researchers, PhD.'s and medical doctors are tirelessly working to find new and leading technologies to help cure the growing amount of sexual dysfunction in today's modern society.

Stay up-to-date with the industries leading minds. Read excerpts from industry journals below.

Featured Articles

The Bolger Conference on PDE-5 Inhibition and HIV Risk: Implications for Health Policy and Prevention.

Recent reports have linked the use of phosphodiesterase type 5 (PDE-5) inhibitors with increased rates of high-risk sexual behavior and HIV transmission.
January 2, 2007

Sexual Behavior, Sexually Transmitted Diseases and Prostatitis: The Risk of Prostate Cancer in Black Men.

Recent studies have suggested a link between chronic inflammation of the male lower urinary tract and development of prostate cancer.
November 14, 2006

Article Library

8 Items

The Bolger Conference on PDE-5 Inhibition and HIV Risk: Implications for Health Policy and Prevention.

Recent reports have linked the use of phosphodiesterase type 5 (PDE-5) inhibitors with increased rates of high-risk sexual behavior and HIV transmission.
January 2, 2007

Sexual Behavior, Sexually Transmitted Diseases and Prostatitis: The Risk of Prostate Cancer in Black Men.

Recent studies have suggested a link between chronic inflammation of the male lower urinary tract and development of prostate cancer.
November 14, 2006

Mediterranean Diet Improves Erectile Function in Subjects with Metabolic Syndrome

The metabolic syndrome consists of a constellation of factors that raise the risk of cardiovascular disease and type 2 diabetes.
October 3, 2006

Effect of Intralesional Interferon-Alpha 2b Combined with Oral Vitamin E for Treatment of Early Stage Peyronie's Disease

Peyronie's disease affects more than 3% of the adult male population and is characterized by scar formation in the penis and many times diminished erectile function. While the exact cause of the disease is unclear, an inflammatory response is commonly implicated.
August 28, 2006

Erectile dysfunction and subsequent cardiovascular disease

Data from the Prostate Cancer Prevention Trial...

Avoidance of Palpable Corporal Fibrosis Due to Priapism with Upregulators of Nitric Oxide.

The authors report the use of an anti-scarring drug treatment to reduce the effects of post-priapism penile tissue scarring...

Predictors and prevalence of erectile dysfunction in a racially diverse population

An analysis of the 2001-2002 release of the National Health and Nutrition Examination Survey...

Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference.

While there has been increasing focus given to the consequence of erectile dysfunctions following treatment for clinically localized prostate cancer, questions arise as to whether men pursue therapy to correct the problem and whether sexual motivation influences this pursuit...